Link to this page
The Drug-Drug Interactions Ontology
| Preferred Name | sufentanil | |
| Synonyms |
N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide sufentanil Sufentanyl C22H30N2O2S N-{4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]piperidin-4-yl}-N-phenylpropanamide N-[4-(methoxymethyl)-1-[2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropanamide sufentanilum N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide |
|
| ID |
http://purl.obolibrary.org/obo/CHEBI_9316 |
|
| activates | ||
| AHFScode |
28:08.08
|
|
| ATCCode |
N01AH03
|
|
| binds |
http://purl.obolibrary.org/obo/dinto_3960 http://purl.obolibrary.org/obo/dinto_2787 |
|
| CASRN |
56030-54-7
|
|
| DBBrand |
sufenta chronogesic
|
|
| DBname |
sufentanil
|
|
| DBSynonym |
sufentanilum [inn-latin] sufentanyl sufentanil citrate
|
|
| Definition |
The carboxamide resulting from the formal condensation of the aryl amino group of 4-(methoxymethyl)-N-phenyl-1-[2-(2-thienyl)ethyl]piperidin-4-amine with propanoic acid.
|
|
| has effect |
http://purl.obolibrary.org/obo/OAE_0000388 http://purl.obolibrary.org/obo/OAE_0000604 http://purl.obolibrary.org/obo/OAE_0000377 http://purl.obolibrary.org/obo/OAE_0000391 http://purl.obolibrary.org/obo/OAE_0000218 http://purl.obolibrary.org/obo/OAE_0001489 http://purl.obolibrary.org/obo/OAE_0000373 http://purl.obolibrary.org/obo/OAE_0000660 http://purl.obolibrary.org/obo/OAE_0000677 http://purl.obolibrary.org/obo/OAE_0000600 http://purl.obolibrary.org/obo/OAE_0000403 http://purl.obolibrary.org/obo/OAE_0000770 http://purl.obolibrary.org/obo/OAE_0000601 http://purl.obolibrary.org/obo/OAE_0000551 http://purl.obolibrary.org/obo/OAE_0000645 http://purl.obolibrary.org/obo/OAE_0000584 http://purl.obolibrary.org/obo/OAE_0000355 |
|
| has pharmacological target | ||
| has role |
http://purl.obolibrary.org/obo/CHEBI_38877 http://purl.obolibrary.org/obo/CHEBI_55322 |
|
| InChI |
InChI=1S/C22H30N2O2S/c1-3-21(25)24(19-8-5-4-6-9-19)22(18-26-2)12-15-23(16-13-22)14-11-20-10-7-17-27-20/h4-10,17H,3,11-16,18H2,1-2H3
|
|
| InChIKey |
InChIKey=GGCSSNBKKAUURC-UHFFFAOYSA-N
|
|
| is metabolised by | ||
| is substrate of | ||
| label |
sufentanil
|
|
| may interact with |
http://purl.obolibrary.org/obo/CHEBI_3699 http://purl.obolibrary.org/obo/dinto_DB00582 http://purl.obolibrary.org/obo/dinto_DB00427 http://purl.obolibrary.org/obo/dinto_DB00752 |
|
| modulates | ||
| prefixIRI |
obo2:CHEBI_9316
|
|
| prefLabel |
sufentanil
|
|
| related with | ||
| SMILES |
CCC(=O)N(c1ccccc1)C1(CCN(CCc2cccs2)CC1)COC CCC(=O)N(C1=CC=CC=C1)C1(COC)CCN(CCC2=CC=CS2)CC1
|
|
| Synonym |
N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide sufentanil Sufentanyl C22H30N2O2S N-{4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]piperidin-4-yl}-N-phenylpropanamide N-[4-(methoxymethyl)-1-[2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropanamide sufentanilum N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide
|
|
| xref |
CiteXplore:10945855 ChEMBL:127638 Reaxys:499558 KEGG COMPOUND:C08022 Drugs.com:http://www.drugs.com/cdi/sufentanil.html CiteXplore:11504823 Drugs Product Database (DPD):2244147 Patent:US3998834 Wikipedia:Sufentanil Wikipedia:http://en.wikipedia.org/wiki/Sufentanil ChEBI:9316 CiteXplore:16621415 BindingDB:50012490 PubChem Compound:41693 Guide To Pharmacology:3534 CiteXplore:9580589 CiteXplore:10628901 CiteXplore:11137863 DrugBank:DB00708 PubChem Substance:46504737 CiteXplore:15475572 CiteXplore:17118343 CiteXplore:15828831 National Drug Code Directory:11098-050-01 Patent:DE2610228 ChemSpider:38043 KEGG DRUG:D05938 CASRN:56030-54-7 IUPHAR:3534 PharmGKB:PA451527
|
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |